The first quarter of 2018 report of Jianfeng Group
Release time:
2021-01-05
公司代码:600668 公司简称:尖峰集团
浙江尖峰集团股份有限公司
2018年第一季度报告正文
一、 重要提示
1.1 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整,不存在虚假记载、误导性陈述或者重大遗漏,并承担个别和连带的法律责任。
1.2 公司全体董事出席董事会审议季度报告。
1.3 公司负责人蒋晓萌、主管会计工作负责人兰小龙及会计机构负责人(会计主管人员)吴德富保证季度报告中财务报表的真实、准确、完整。
1.4 本公司第一季度报告未经审计。
二、 公司主要财务数据和股东变化
2.1 主要财务数据
单位:元 币种:人民币
|
|
本报告期末 |
上年度末 |
本报告期末比上年度末增减(%) |
|
总资产 |
4,366,775,455.41 |
4,175,730,846.73 |
4.58 |
|
归属于上市公司股东的净资产 |
2,757,802,176.89 |
2,627,318,888.65 |
4.97 |
|
|
年初至报告期末 |
上年初至上年报告期末 |
比上年同期增减(%) |
|
经营活动产生的现金流量净额 |
13,967,176.23 |
317,755.25 |
4,295.58 |
|
|
年初至报告期末 |
上年初至上年报告期末 |
比上年同期增减(%) |
|
营业收入 |
669,522,008.06 |
566,846,953.96 |
18.11 |
|
归属于上市公司股东的净利润 |
104,344,646.12 |
112,200,485.23 |
-7.00 |
|
归属于上市公司股东的扣除非经常性损益的净利润 |
98,932,514.65 |
108,827,872.82 |
-9.09 |
|
加权平均净资产收益率(%) |
3.89 |
4.57 |
减少0.68个百分点 |
|
基本每股收益(元/股) |
0.3032 |
0.3260 |
-7.00 |
|
稀释每股收益(元/股) |
0.3032 |
0.3260 |
-7.00 |
非经常性损益项目和金额
单位:元 币种:人民币
|
项目 |
本期金额 |
说明 |
|
非流动资产处置损益 |
-25,888.87 |
|
|
越权审批,或无正式批准文件,或偶发性的税收返还、减免 |
|
|
|
计入当期损益的政府补助,但与公司正常经营业务密切相关,符合国家政策规定、按照一定标准定额或定量持续享受的政府补助除外 |
6,648,601.60 |
|
|
委托他人投资或管理资产的损益 |
270,624.68 |
|
|
除上述各项之外的其他营业外收入和支出 |
-166,308.37
|
|
|
少数股东权益影响额(税后) |
-196,583.34 |
|
|
所得税影响额 |
-1,118,314.23 |
|
|
合计 |
5,412,131.47 |
|
2.2 截止报告期末的股东总数、前十名股东、前十名流通股东(或无限售条件股东)持股情况表
单位:股
|
股东总数(户) |
27,298 |
||||||
|
前十名股东持股情况 |
|||||||
|
股东名称(全称) |
期末持股 数量 |
比例(%) |
持有有限售条件股份数量 |
质押或冻结情况 |
股东性质 |
||
|
股份状态 |
数量 |
||||||
|
金华市通济国有资产投资有限公司 |
55,564,103 |
16.15 |
0 |
无 |
0 |
国有法人 |
|
|
新余中盛恒兴投资管理合伙企业(有限合伙 |
17,158,922 |
4.99 |
0 |
无 |
0 |
未知 |
|
|
新余汇恒瑞投资管理合伙企业(有限合伙) |
12,665,208 |
3.68 |
0 |
无 |
0 |
未知 |
|
|
香港中央结算有限公司 |
4,372,091 |
1.27 |
0 |
无 |
0 |
未知 |
|
|
刘锦春 |
3,874,269 |
1.13 |
0 |
无 |
0 |
境内自然人 |
|
|
钟以隆 |
3,584,000 |
1.04 |
0 |
无 |
0 |
境内自然人 |
|
|
苏志伟 |
3,226,848 |
0.94 |
0 |
无 |
0 |
境内自然人 |
|
|
王晓红 |
3,121,943 |
0.91 |
0 |
无 |
0 |
境内自然人 |
|
|
骆惠娟 |
2,726,200 |
0.79 |
0 |
无 |
0 |
境内自然人 |
|
|
中国工商银行股份有限公司-南方大数据100指数证券投资基金 |
2,667,200 |
0.78 |
0 |
无 |
0 |
未知 |
|
|
前十名无限售条件股东持股情况 |
|||||||
|
股东名称 |
持有无限售条件流通股的数量 |
股份种类及数量 |
|||||
|
种类 |
数量 |
||||||
|
金华市通济国有资产投资有限公司 |
55,564,103 |
人民币普通股 |
55,564,103 |
||||
|
新余中盛恒兴投资管理合伙企业(有限合伙 |
17,158,922 |
人民币普通股 |
17,158,922 |
||||
|
新余汇恒瑞投资管理合伙企业(有限合伙) |
12,665,208 |
人民币普通股 |
12,665,208 |
||||
|
香港中央结算有限公司 |
4,372,091 |
人民币普通股 |
4,372,091 |
||||
|
刘锦春 |
3,874,269 |
人民币普通股 |
3,874,269 |
||||
|
钟以隆 |
3,584,000 |
人民币普通股 |
3,584,000 |
||||
|
苏志伟 |
3,226,848 |
人民币普通股 |
3,226,848 |
||||
|
王晓红 |
3,121,943 |
人民币普通股 |
3,121,943 |
||||
|
骆惠娟 |
2,726,200 |
人民币普通股 |
2,726,200 |
||||
|
中国工商银行股份有限公司-南方大数据100指数证券投资基金 |
2,667,200 |
人民币普通股 |
2,667,200 |
||||
|
上述股东关联关系或一致行动的说明 |
本公司第一大股东通济国投与其他上述第2名至第10名无限售条件股东之间不存在关联关系。公司未知其他9名股东之间是否存在关联关系,也未知是否属于《上市公司收购管理办法》规定的一致行动人。 |
||||||
|
表决权恢复的优先股股东及持股数量的说明 |
不适用 |
||||||
2.3 截止报告期末的优先股股东总数、前十名优先股股东、前十名优先股无限售条件股东持股情况表
三、 重要事项
3.1 公司主要会计报表项目、财务指标重大变动的情况及原因
|
单位:万元 |
||||
|
资产负债表项目 |
期末数 |
期初数 |
变动幅度 |
变动原因 |
|
预付款项 |
9,726.83 |
4,610.82 |
110.96% |
主要系本报告期子公司预付货款增加所致。 |
|
应收股利 |
2,076.00 |
|
100.00% |
主要系报告期公司按被投资单位天士力控股集团有限公司2017年度利润分配的股东会决议计入应收的现金股利所致。 |
|
其他应收款 |
1,997.52 |
1,308.75 |
52.63% |
主要系报告期公司及子公司存出保证金增加所致。 |
|
其他流动资产 |
925.10 |
1,328.92 |
-30.39% |
主要系报告期子公司抵扣了上年取得的留抵进项税所致。 |
|
短期借款 |
16,800.00 |
8,900.00 |
88.76% |
主要系报告期公司银行贷款增加所致。 |
|
应付职工薪酬 |
1,279.67 |
3,627.55 |
-64.72% |
主要系报告期公司及子公司发放上年末计提的年终奖所致。 |
|
应付利息 |
1,579.21 |
934.17 |
69.05% |
主要系报告期公司计提应付债券利息以及由于银行借款增加相应计提利息增加所致。 |
|
应付股利 |
2,520.16 |
120.16 |
1997.38% |
主要系报告期子公司股东会决议已宣告发放2017年度现金股利所致。 |
|
利润表项目 |
本期数 |
上年同期数 |
变动幅度 |
变动原因 |
|
税金及附加 |
551.67 |
336.88 |
63.76% |
主要系报告期子公司应交税费增加所致。 |
|
销售费用 |
10,678.03 |
4,772.03 |
123.76% |
主要系报告期子公司尖峰药业销售收入的增长和销售模式的调整,公司销售费用中增加了市场推广费和其他支出。 |
|
投资收益 |
1,950.22 |
6,087.10 |
-67.96% |
主要系报告期公司联营投资单位天士力控股集团有限公司利润大幅减少,公司权益法核算计入投资收益相应减少所致。 |
|
其他收益 |
502.73 |
0.00 |
100.00% |
主要系本报告期公司按新会计准则要求将与公司日常活动有关的政府补助从“营业外收入”科目转入所致。 |
|
营业外收入 |
171.06 |
485.84 |
-64.79% |
主要系本报告期公司按新会计准则要求将与公司日常活动有关的政府补助转入“其他收益”项目所致。 |
|
营业外支出 |
27.23 |
4.66 |
483.87% |
主要系报告期子公司营业外支出增加所致。 |
|
所得税费用 |
3,098.44 |
1,981.63 |
56.36% |
主要系本报告期子公司实现的利润总额增加相应的所得税费用增加所致。 |
|
现金流量表项目 |
|
|
|
|
|
经营活动产生的现金流量净额 |
1,396.72 |
31.78 |
4295.58% |
主要系报告期由于公司经营活动现金流入增加所致。 |
|
投资活动产生的现金流量净额 |
-9,823.08 |
-2,287.17 |
|
主要系报告期子公司对外投资及在建项目投入增加所致。 |
|
筹资活动产生的现金流量净额 |
7,779.59 |
-210.06 |
|
主要系报告期公司增加了银行借款所致。 |
3.2 重要事项进展情况及其影响和解决方案的分析说明
1、2017年2月28日,公司九届10次董事会通过了《关于子公司对外投资的议案》,公司控股子公司尖峰药业拟以增资和股权转让的方式分期对北慧生物进行投资;2018年3月31日,公司披露了对外投资进展情况。上述事项详见2017年3月1日、2018年3月31日本公司披露于上海证券交易所网站(http//:www.sse.com.cn/)的临2017-003《关于子公司对外投资的公告》、临2018-003《关于子公司对外投资的进展公告》。
2、2018年1月19日,本公司十届2次董事会通过了《关于子公司尖峰药业对外投资的议案》,尖峰药业拟投资11132.79万元以收购股份和增资的方式对上海北卡进行投资。投资完成后,上海北卡注册资本由原来的1100万元增加至1755.55万元,其中尖峰药业占55%。上述事项详见2018年1月20日本公司披露于上海证券交易所网站(http//:www.sse.com.cn/)的临2018-002《关于子公司尖峰药业对外投资的公告》。截止报告期末,尖峰药业已经按照协议约定,支付了第一期股权转让款和增资款。目前正在办理资产交接、工商变更登记手续。
3、2017年4月15日,公司九届11次董事会通过了《关于尖峰国贸新建仓库(电商物流园)项目的议案》,批准控股子公司尖峰国贸投资7500万元新建仓库(电商物流园)。2017年6月6日,公司九届13次董事会通过了《关于尖峰国贸仓库出租的议案》,同意尖峰国贸将该新建仓库(电商物流园)的仓库、堆场、停车场等物业出租给上海安能聚创供应链管理有限公司。上述事项详见2017年4月18日、2017年6月7日披露于上海证券交易所网站(http//:www.sse.com.cn/) 的临2017-006《九届11次董事会决议公告》和临2017-013《九届13次董事会决议公告》。截止3月底,该项目累计已投入资金3909.65万元。
3.3 报告期内超期未履行完毕的承诺事项
3.4 预测年初至下一报告期期末的累计净利润可能为亏损或者与上年同期相比发生重大变动的警示及原因说明
|
公司名称 |
浙江尖峰集团股份有限公司 |
|
法定代表人 |
蒋晓萌 |
|
日期 |
2018年4月27日 |
- 发布时间: 2018-04-28
More information
Spike Health was identified as Zhejiang Agricultural Science and Technology R & D Center
Zhejiang Provincial Department of science and technology recently issued a notice, peak health technology company research and development center was identified as Zhejiang agricultural science and technology research and development center. According to the relevant requirements, Zhejiang agricultural science and technology research and development center must be established with national and provincial agricultural leading enterprises, agricultural science and technology enterprises or other scientific and technological agricultural enterprises with high scientific and technological content as the carrier, with strong economic strength and scientific and technological research and development foundation; The annual sales income of the enterprise is more than 10 million yuan, and the R & D center has more than 10 full-time technicians, of whom more than 30% have bachelor's degree or above; the annual technology development funds shall not be less than 3% of the sales revenue of the enterprise; it has the necessary instruments and equipment and fixed and special places to meet the research and development; it has the conditions for the application of agricultural technology information network. The main business of the enterprise is clear, and it is the priority industry in our province. The technological innovation achievements have a wide range of radiation, the enterprise system is sound, and the operating mechanism is good. With the domestic, provincial institutions of higher learning, scientific research units have established a stable relationship of scientific research cooperation. Since its establishment, Jianfeng Health has attached great importance to the construction of innovation platform and the cultivation of scientific and technological talents. In 2016, it has been recognized as Jinhua agricultural science and technology enterprise and municipal agricultural science and technology research and development center. In 2017, research and development investment accounted for 5.06 of sales revenue, and full-time research and development personnel with bachelor's degree or above accounted for 80.9, consisting of talents including traditional Chinese medicine, traditional Chinese medicine preparation, agriculture and biotechnology, pharmacy, analysis, plant extraction, food engineering, etc. Dr. Li Wende, head of the research and development center, was also selected "Jinhua Shuanglong plan talent" in 2017 ". In recent years, peak health and Zhejiang workers.
2020
07-31
Chairman Jiang Xiaomeng Directs Work in Yunnan Peak
On December 16, Jiang Xiaomeng, Secretary of the Party committee and chairman of the group company, went to Yunnan Jianfeng cement company to investigate and guide the work. On the morning of the same day, accompanied by the Yunnan peak management team, Jiang Xiaomeng went deep into the front line and successively went to the central control room of the production and manufacturing department, the raw material clay yard, the lignite yard and other areas for field investigation and investigation to understand the problems existing in the production and operation process. Subsequently, a business analysis meeting was held to make a comparative analysis of the various business indicators of Yunnan Jianfeng from January to November this year, and put forward two requirements to the management team: further strengthen internal management and improve execution; strengthen the coordination of external relations, and improve The ability and level of enterprise resource acquisition. At the Yunnan Jianfeng middle-level cadre meeting held on the afternoon of the 16th, Jiang Xiaomeng first fully affirmed Yunnan Jianfeng's highest output and best benefits since it was put into production in 2018, and expressed his gratitude to all cadres and employees of Yunnan Jianfeng for their hard work. After that, Jiang Xiaomeng made a detailed analysis of the cement industry and the regional market environment in Yunnan, and combined with the current production and operation situation of Yunnan Jianfeng, put forward the focus of the next step: 1. should fully attach importance to and mobilize the initiative and responsibility of employees at all levels to improve the overall execution of the team; 2. raw material mines are an important factor restricting the future development of cement enterprises, which should be paid full attention to and formulate clear strategies and methods, set out a timetable to obtain future production resources as much as possible; 3. continuously advocate and promote technological innovation, keep pace with the times, continuously improve production management, equipment management, production technology level, and maintain the competitive advantage of the industry; 4. further strengthen production
2020
07-31
Chairman Jiang Xiaomeng Directs Work in Yunnan Peak
On December 16, Jiang Xiaomeng, Secretary of the Party committee and chairman of the group company, went to Yunnan Jianfeng cement company to investigate and guide the work. On the morning of the same day, accompanied by the Yunnan peak management team, Jiang Xiaomeng went deep into the front line and successively went to the central control room of the production and manufacturing department, the raw material clay yard, the lignite yard and other areas for field investigation and investigation to understand the problems existing in the production and operation process. Subsequently, a business analysis meeting was held to make a comparative analysis of the various business indicators of Yunnan Jianfeng from January to November this year, and put forward two requirements to the management team: further strengthen internal management and improve execution; strengthen the coordination of external relations, and improve The ability and level of enterprise resource acquisition. At the Yunnan Jianfeng middle-level cadre meeting held on the afternoon of the 16th, Jiang Xiaomeng first fully affirmed Yunnan Jianfeng's highest output and best benefits since it was put into production in 2018, and expressed his gratitude to all cadres and employees of Yunnan Jianfeng for their hard work. After that, Jiang Xiaomeng made a detailed analysis of the cement industry and the regional market environment in Yunnan, and combined with the current production and operation situation of Yunnan Jianfeng, put forward the focus of the next step: 1. should fully attach importance to and mobilize the initiative and responsibility of employees at all levels to improve the overall execution of the team; 2. raw material mines are an important factor restricting the future development of cement enterprises, which should be paid full attention to and formulate clear strategies and methods, set out a timetable to obtain future production resources as much as possible; 3. continuously advocate and promote technological innovation, keep pace with the times, continuously improve production management, equipment management, production technology level, and maintain the competitive advantage of the industry; 4. further strengthen production
2020
07-30
Editor's note: On November 20, the first page of "Jinhua Daily" published "Focus on sticking to the peak forever-Enlightenment of Jianfeng Group's 60 years of entrepreneurship" written by the reporter of the newspaper, which was specially reprinted by this newspaper. Focus on sticking to the peak forever-Jianfeng Group's 60 years of entrepreneurship enlightenment "Jinhua Daily" reporter Shao Xuilian as of the end of the third quarter of this year, the total assets of 4.788 billion yuan, net assets of 3.366 billion yuan, the realization of the parent company's net profit of 0.488 billion yuan, earnings per share of 1.42 yuan. Recently, Jianfeng Group disclosed its beautiful report for the third quarter of 2018, celebrating its 60th anniversary with the best operating results in history. Wind and rain for 60 years. With sustained and steady high-quality development, the peak people are moving towards a comprehensive modern enterprise group with strong core competitiveness. Strategy: Focus and Professionalism In 1958, the first generation of peak people built the first cement factory in Jinhua history at the foot of peak mountain. Beginning in 1983, through horizontal alliances with township enterprises, the formation of enterprise groups, and the implementation of shareholding reforms, Jianfeng has developed from a small state-owned cement plant to the first listed company in China's cement industry. Since then, in the stage of diversification, the peak will develop the pharmaceutical industry into the second pillar industry. In 2007, it joined forces with the central enterprise China Building Materials to participate in the establishment of Southern Cement and strategically shifted the focus of the cement industry; at the same time, through corporate mergers and acquisitions and technological innovation, the pharmaceutical industry has further exerted its strength. Today, Jianfeng Group has 33 participating and holding subsidiaries, involving building materials, medicine, big health, modern logistics, national.
2020
07-31
News from our newspaper On the occasion of the celebration of the 60th anniversary of Jianfeng's entrepreneurship, the selection results of the two competitions of "Me and Jianfeng" essay and employee calligraphy and painting photography exhibition are also fresh. Since July 2017, more than 50 contributions have been received from employees and their families. According to the overall situation of the content and writing level of the solicitation, 3 first prize works, 5 second prize works and 7 third prize works were selected. The staff calligraphy and painting photography exhibition began to call for contributions in early April. in just five months, it received more than 100 works from dozens of authors from various enterprises under the group, and successfully held the exhibition from October 10 to 17, which was welcomed and praised by the majority of employees. After a comprehensive selection of employee contributions, a total of 3 first-class works, 5 second-class works, and 7 third-class works were selected. In order to ensure the fairness and impartiality of the selection, the works of the leading group, working group members and specially invited works to commemorate the 60th anniversary of Jianfeng Entrepreneurship will not participate in the selection of the grade award. (The list of winners is attached) (This reporter) "I and the peak" essay list first prize "mother and son deep love" author: Daye peak Shi Fu "I have a date with the peak" author: Yunnan peak Luo Meiyan "buying a house" author: peak cable Lu Chaofang second prize "ten years, sixty years" author: pharmaceutical sales company Xu Yuting "my peak road" author: daye Peak Yang Zhendong's "My Teacher" Author: Fan Tufa, Municipal Pharmaceutical Company, "Peak Grows with Me for 20 Years" Author: Xu Junxiong, Pharmaceutical Sales Company, "Peak Grows with Me"
2020
07-31